Idiopathic inflammatory myopathy
Not recruitingStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
- Disease:Idiopathic inflammatory myopathy
The Netherlands- Participants:18–64 years · 65+ years











